Trial · NCT07902063
Clinical And Radiographic Assessment of H-shaped Bone Plates in Management of Body and Angle Mandibular Fractures
NCT07902063, Not applicable, Not yet recruiting, Suez Canal University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Clinical And Radiographic Assessment of H-shaped Bone Plates in Management of Body and Angle Mandibular Fractures. Trials, record NCT07902063. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07902063
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Clinical And Radiographic Assessment of H-shaped Bone Plates in Management of Body and Angle Mandibular Fractures
- NCT number
- NCT07902063
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 16 participants, estimated
- Lead sponsor
- Suez Canal University
- Conditions
- Mandibular Angle Fractures, Mandibular Body Fractures
- Interventions
- open reduction and fixation of the fracture, open reduction and fixation of body and angle mandible fracture
- First posted
- 2026-10-28
- Last updated
- 2026-10-28
Source ClinicalTrials.gov
Registered outcomes4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Postoperative Pain Intensity as Assessed by a Visual Analogue Scale (VAS) at 1 and 7 Days Postoperatively | one to seven days after operation | The Visual Analogue Scale (VAS) consists of a 10-centimeter (cm) line, with two endpoints representing a minimum value of 0 ("no pain") and a maximum value of 10 ("pain as bad as it could possibly be"). Patients rate their current level of pain by placing a mark on the line. Higher scores indicate a worse outcome (increased pain intensity). |
| Primary | Postoperative Facial Edema as Measured by the Tape Measuring Test at 1 and 7 Days Postoperatively | one to seven days after operation | Facial swelling is quantified using a flexible tape measure while the patient is seated upright with teeth in occlusion. Measurements are recorded in centimeters (cm) as the sum of two lines connecting four predetermined facial reference points: ear tragus to the corner of the mouth, and gonion to the external canthus of the eye. Changes occurring between the follow-up intervals and baseline will be reported. An increase in the sum of these measurements indicates a worse outcome (increased swelling). |
| Primary | Proportion of Participants with Stable Fracture Segments as Assessed by Bimanual Digital Manipulation at 1 and 7 Days Postoperatively | one to seven days | Bimanual digital manipulation is performed clinically by the investigator to evaluate the mobility of the bone fracture segments. Fracture segment stability is recorded as a categorical outcome: 1) "Stable" (indicating no movement of fragments, representing a successful/better outcome) or 2) "Nonstable" (indicating the presence of movement, representing a worse outcome). |
| Primary | Change from Baseline in Radiographic Bone Density at the Fracture Line at 1 and 4 Months Postoperatively | Immediate postoperatively (baseline), 1 month, and 4 months postoperative | Panoramic radiographs are performed using a digital panoramic machine to evaluate progressive bone healing. Bone density is quantified by measuring the radiographic gray-scale values at the site of the plate over the fracture line using OnDemand software. An increase in gray-scale value over time relative to the immediate postoperative baseline indicates progressive bone healing and successful bone union, representing a better outcome. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07902063
GET https://conductscience.org/api/trials/v1/NCT07902063/registered